František Babič

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 11

Top Topics

Systematic Review

Cognitive Impairment

Top Venues

International journal of environmental research and public health

Healthcare (Basel, Switzerland)

Medical science monitor : international medical journal of experimental and clinical research

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Zvonimir Bosnic, František Babič, Viera Anderková, Ljiljana Trtica Majnaric, Thomas Wittlinger, Ljiljana Trtica Majnarić
A Critical Appraisal of the Diagnostic and Prognostic Utility of the Anti-Inflammatory Marker IL-37 in a Clinical Setting: A Case Study of Patients with Diabetes Type 2. International journal of environmental research and public health 20 (4) (2023)
Zvonimir Bosnic, František Babič, Viera Anderková, Ljiljana Trtica Majnaric, Thomas Wittlinger, Ljiljana Trtica Majnarić
A Critical Appraisal of the Diagnostic and Prognostic Utility of the Anti-Inflammatory Marker IL-37 in a Clinical Setting: A Case Study of Patients with Diabetes Type 2. International journal of environmental research and public health 20 (4) (2023)
Marek Malík, Anton Dzian, Martin Števík, Štefánia Vetešková, Abdulla Al Hakim, Maroš Hliboký, Ján Magyar, Michal Kolárik, Marek Bundzel, František Babič
Lung Ultrasound Reduces Chest X-rays in Postoperative Care after Thoracic Surgery: Is There a Role for Artificial Intelligence?-Systematic Review. Diagnostics (Basel, Switzerland) 13 (18) (2023)
Zvonimir Bosnic, František Babič, Viera Anderková, Ljiljana Trtica Majnaric, Thomas Wittlinger, Ljiljana Trtica Majnarić
A Critical Appraisal of the Diagnostic and Prognostic Utility of the Anti-Inflammatory Marker IL-37 in a Clinical Setting: A Case Study of Patients with Diabetes Type 2. International journal of environmental research and public health 20 (4) (2023)
Zvonimir Bosnic, František Babič, Viera Anderková, Ljiljana Trtica Majnaric, Thomas Wittlinger, Ljiljana Trtica Majnarić
A Critical Appraisal of the Diagnostic and Prognostic Utility of the Anti-Inflammatory Marker IL-37 in a Clinical Setting: A Case Study of Patients with Diabetes Type 2. International journal of environmental research and public health 20 (4) (2023)
Zvonimir Bosnić, František Babič, Thomas Wittlinger, Viera Anderková, Ines Šahinović, Ljiljana Trtica Majnarić
Influence of Age, Gender, Frailty, and Body Mass Index on Serum IL-17A Levels in Mature Type 2 Diabetic Patients. Medical science monitor : international medical journal of experimental and clinical research 29 (2023)
Zvonimir Bosnic, František Babič, Viera Anderková, Ljiljana Trtica Majnaric, Thomas Wittlinger, Ljiljana Trtica Majnarić
A Critical Appraisal of the Diagnostic and Prognostic Utility of the Anti-Inflammatory Marker IL-37 in a Clinical Setting: A Case Study of Patients with Diabetes Type 2. International journal of environmental research and public health 20 (4) (2023)
Karel Mls, Milan Kořínek, Kamila Štekerová, Petr Tučník, Vladimír Bureš, Pavel Čech, Martina Husáková, Peter Mikulecký, Tomáš Nacházel, Daniela Ponce, Marek Zanker, František Babič, Ioanna Triantafyllou
Agent-based models of human response to natural hazards: systematic review of tsunami evacuation. Natural hazards (Dordrecht, Netherlands) (2022)
Ljiljana Trtica Majnaric, František Babič, Shane O'Sullivan, Andreas Philipp Hassler
AI and Big Data in Healthcare: Towards a More Comprehensive Research Framework for Multimorbidity. Journal of clinical medicine 10 (4) (2021)
Sanja Bekić, František Babič, Viera Pavlišková, Ján Paralič, Thomas Wittlinger, Ljiljana Trtica Majnaric
Clusters of Physical Frailty and Cognitive Impairment and Their Associated Comorbidities in Older Primary Care Patients. Healthcare (Basel, Switzerland) 9 (7) (2021)
Zvonimir Bosnic, Pinar Yildirim, František Babič, Ines Šahinović, Thomas Wittlinger, Ivo Martinović, Ljiljana Trtica Majnaric
Clustering Inflammatory Markers with Sociodemographic and Clinical Characteristics of Patients with Diabetes Type 2 Can Support Family Physicians' Clinical Reasoning by Reducing Patients' Complexity. Healthcare (Basel, Switzerland) 9 (12) (2021)